SMALL MOLECULE OUTSOURCING
Taste Masking 101: Sensory And Performance Evaluation
Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.
New Approaches To Tailored Release Profiles
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
A Data-Driven Approach To Container Closure Integrity
Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.
Cambrex Scientist Spotlight: Elena Bejan
Holding a Ph.D. in organic chemistry from Paris-Sud University and an MBA from the Rotman School of Management, Bejan leads R&D efforts at Cambrex with a focus on scientific innovation.
Sustainability By Design In API Manufacturing
Explore the urgent need for sustainability in small molecule API manufacturing, as well as reveal regulatory drivers, green chemistry innovations, and practical strategies to reduce emissions.
Cambrex Scientist Spotlight: Daniel Kirschner
With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.
Solid Formulation: Spray Drying Process
Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.
Small Molecule APIs: From Pre-RSM To Final API
As a leader in small molecule manufacturing, Ajinomoto Bio-Pharma Services has over 40 years of experience providing high quality APIs and intermediates for pharmaceutical companies throughout the world.
Challenges With Pediatric Flavors For Taste Enhancement And Modulation
Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.
Expanding The OSD Toolbox
This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.
Managing Nitrite Impurities: Supplier-Manufacturer View
Examine nitrites in excipients, nitrosamine risks, regulatory considerations, analytical controls, and a case study on mitigating risks in pharmaceutical manufacturing and storage.
How To Deal With The Complexity Of Drugs In Clinical Development
Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.
CESS Technology
Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.
Taste Masking 101: Applications And Technologies
Learn about key product parameters affecting patient acceptability and therapy adherence and taste masking strategies, including organoleptic and barrier coating approaches and microencapsulation technologies.
Innovative Technology For Developing, Scaling Peptide-Based Therapeutics
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.
Nanoparticle Enabled Formulation And Drug Delivery Solutions
Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.
Calcium Carbonate As TiO2 Alternative In Coating
Explore how calcium carbonate can replace titanium dioxide in tablet coating, as well as learn formulation strategies and review color performance data to support high-quality finishes in applications.
ADHD Awareness: How This Novel Technology Can Guide The Way
Explore Nanoform's innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders such as ADHD.
The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
OPTIMA 7000 Fill Line
Ajinomoto Bio-Pharma Services is a leader in aseptic filling, offering a wide range of capabilities for vials with our OPTIMA 7000 fill line. The OPTIMA VFVM 7000 safely processes various types and classes of biopharmaceutical products in 2 mL to 100 mL sizes.
Pressure Testing Your Readiness To Ensure GMP Batch #1 Success
Watch as an expert from an industry-leading CDMO provides insights into the crucial factors, challenges, and tech transfer methods needed to achieve right-first-time readiness and success.
Developing Long-Acting Contraceptive Injectables
Adare Pharma Solutions is crafting contraceptive injections that can last up to a year, increasing accessibility and allowing women to choose protection on their own terms.
How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma
Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).
The Paradigm Shift To Continuous Flow Processes: A Holistic View
A clear increase in continuous flow processes has emerged over the past decade, thanks to the commercialization of preparative flow reactor units.
Environmental Sustainability: Wastewater Incineration Reduction
Discover an approach to wastewater treatment that reduces the environmental impact of small molecules production and introduces advanced treatment methodologies to avoid wastewater incineration.
AI Based Screening And Selection Of Co-Formers For Co-Crystallization
Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.
Understanding FDA Calibration Requirements And Best Practices For Reducing Risks
Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.
From Powder To Particles With Jet Milling
Gain valuable insights into the jet milling process and Quality by Design approach for inhalation drug delivery and their potential applications in drug development.
Improve The Bioavailability Of Poorly Soluble Drugs
KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.
Your Journey To GMP With Emphasis On Linker Payload Development
Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.
Strategic CMC Planning Through A Phase-Appropriate Quality Approach
A phase-appropriate quality approach ensures quality activities align with the unique risks and challenges of each development stage. Watch to learn how to apply such an approach to chemistry, manufacturing, and controls planning.
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
Little Patients, Big Challenges: Developing Pediatric Formulations
Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.
Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.
Patient- And Planet-Centric Bioavailability And Sustained Delivery
By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.
Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.